chevron_leftBack
As of 13 June 2026, Sinsin Pharmaceutical Co., Ltd. has a market cap of $59.05M USD, ranking #29364 globally and #1609 in South Korea.
It ranks #2658 in the Healthcare sector, and #943 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$59.05MUSD
89.81B KRW
Enterprise Value
$84.73MUSD
129.32B KRW
Revenue (TTM)
$74.81MUSD
113.78B KRW
EBITDA (TTM)
$9.79MUSD
14.94B KRW
Net Income (TTM)
$6.11MUSD
9.29B KRW
EBITDA Margin
13%
Profit Margin
8.2%
PE Ratio
9.7
PS Ratio
0.8
PB Ratio
1.2
EV/EBITDA
8.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ki Lee Byoung
open_in_new
Employees
356
Founded
1959
Website
sinsin.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.8% | 2.7% | 7.7% | 5.1% | 13% | -4.9% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002800
신신제약(주)
ISIN: KR7002800001
Shares Out.:
Shares Outstanding:
15.171M1
Shares Float:
7.271M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
5,920 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sinsin Pharmaceutical Co., Ltd.
Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The company was founded in 1959 and is headquartered in Sejong, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
15K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
11K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
9K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
8K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
8K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
7K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
927K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
611K%
|
97.4
|
|
SIX: RO
|
$321.52B
544K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
489K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
465K%
218.9B CHF
|
20.5
|
chevron_leftBack